| Entry |
|
|---|
| Name |
Teceleukin (USAN);
Teceleukin (genetical recombination) (JP18);
Imunace (TN) |
|---|
| Formula |
C698H1127N179O204S8
|
|---|
| Exact mass |
15537.1082
|
|---|
| Mol weight |
15547.03
|
|---|
| Sequence |
MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL
EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN
RWITFCQSII STLT (Disulfid bridge: 59-106) |
|---|
| Type |
Peptide |
|---|
| Remark |
| Therapeutic category: | 6399 |
|
|---|
| Efficacy |
Antineoplastic, Immunostimulant, Biological response modifier |
|---|
| Comment |
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
639 Miscellaneous
6399 Others
D02749 Teceleukin (USAN); Teceleukin (genetical recombination) (JP18)
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interleukin receptors
IL2RA (CD25)
D02749 Teceleukin (USAN) <JP>
IL2RB (CD122)
D02749 Teceleukin (USAN) <JP>
IL2RG (CD132)
D02749 Teceleukin (USAN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D02749 Teceleukin (genetical recombination)
D02749 Teceleukin for injection (genetical recombination)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
